文献速递免疫规划传染病防控与疫情报告

芬兰国家免疫规划项目实施后轮状病毒疫苗接种的长期监测(2008-2018年)

Long-term surveillance of rotavirus vaccination after implementation of a national immunization program in Finland (2008-2018).
PubMed 文献 · Vaccine · 2022-05-28

研究分析芬兰2008-2011年出生儿童至2018年底的轮状病毒胃肠炎(RVGE)、病毒性胃肠炎(VGE)和急性胃肠炎(AGE)住院及门诊就诊发病率,并按出生年份分为未 eligible、部分 eligible 和疫苗 eligible 队列。结果显示疫苗接种后RVGE发病率显著下降,疫苗 eligible 队列中未观察到6岁后RVGE病例,高接种率地区RVGE发病率低于低接种率地区。

要点

  • 疫苗 eligible 队列中未观察到6岁后RVGE病例,而未 eligible 和部分 eligible 队列中有病例。
  • 芬兰全国平均疫苗接种覆盖率超过90%,高覆盖率地区RVGE发病率低于低覆盖率地区。
  • 引入RV疫苗后10年内所有年龄组RVGE发病率保持低位。

核心结论

  • 在芬兰国家免疫规划引入轮状病毒疫苗后的10年内,所有年龄组RVGE发病率保持低位。
  • 高疫苗接种覆盖率地区与较低覆盖率地区之间RVGE发病率存在差异,凸显维持高疫苗接种覆盖率的重要性。

研究设计与样本

  • 研究描述2008-2011年出生的所有芬兰儿童的RVGE、VGE和AGE发病率,按出生年份分为未 eligible(2008年出生)、部分 eligible(2009年出生)和疫苗 eligible(2010年和2011年出生)队列。
  • 从国家护理登记处收集所有儿童从出生至2018年12月31日的住院和门诊数据。
  • 研究还分析了2014-2017年3岁以下儿童在疫苗接种覆盖率90%及以上和低于90%的市镇的RVGE发病率。

主要发现

  • 国家免疫规划实施RV疫苗接种后,RVGE发病率很快显著下降。
  • 在疫苗 eligible 队列中,未观察到最小年龄组出现明显的发病高峰,且接种疫苗后6年以上未观察到RVGE病例,这与疫苗未 eligible 和部分 eligible 队列形成对比。
  • 尽管芬兰总体疫苗接种覆盖率较高,高覆盖率地区的RVGE发病率低于覆盖率较低的地区。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Rotavirus (RV) vaccination was included in the Finnish National immunization Program (NIP) in 2009. RotaTeq (RV5) has been used exclusively with a national average vaccination coverage rate (VCR) of > 90%. While previous studies have demonstrated that inpatient rotavirus gastroenteritis (RVGE) admissions declined by as much as 96% in Finnish children ≤ 5 years old following RV vaccination introduction, no study has evaluated long-term protection after vaccination in Finland. In this study, we analyze incidence of hospital outpatient visits and inpatient admissions of gastroenteritis in children up to 7 years of age. METHODS: We first describe the incidence of RVGE, viral gastroenteritis (VGE), and acute gastroenteritis (AGE) for all Finnish children born during 2008-2011. Children were stratified by the year of birth into not-eligible, partially eligible and rotavirus vaccine-eligible (born in 2008, 2009, 2010 and 2011, respectively). Hospital inpatient and outpatient data was collected from the National Care Register for all children from birth until December 31st, 2018. We also studied RVGE incidence during 2014-2017 for children<3 years of age in municipalities with VCRs of 90% and above and municipalities with VCRs below 90%. RESULTS: RVGE incidence decreased significantly soon after implementation of RV vaccination in the NIP. In vaccine-eligible cohorts, no clear peak incidence in the youngest age groups could be observed, and no RVGE cases were observed beyond 6 years after vaccination, in contrast to vaccine ineligible and partially eligible cohorts. Despite an overall high VCR in Finland, regions with high VCR had lower incidence of RVGE than regions with lower VCR. CONCLUSION: Incidence of RVGE has remained low in all age groups during the 10 years following introduction of RV vaccine in the Finnish NIP. Differences in RVGE incidence were observed in regions with high as compared with lower VCR, highlighting the importance of maintaining high vaccination coverage.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Hemming-Harlo M, Gylling A, Herse F, et al. Long-term surveillance of rotavirus vaccination after implementation of a national immunization program in Finland (2008-2018). Vaccine. 2022. PMID: 35641360. doi:10.1016/j.vaccine.2022.04.104

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。